Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Retained Earnings (2022 - 2025)

NewGenIvf (NIVF) has disclosed Retained Earnings for 4 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 47017.43% to $8.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, up 47017.43% year-over-year, with the annual reading at $8.9 million for FY2025, 47017.43% up from the prior year.
  • Retained Earnings for Q4 2025 was $8.9 million at NewGenIvf, up from $18875.0 in the prior quarter.
  • The five-year high for Retained Earnings was $8.9 million in Q4 2025, with the low at -$461351.0 in Q4 2023.
  • Average Retained Earnings over 4 years is $2.1 million, with a median of $14222.5 recorded in 2022.
  • The sharpest move saw Retained Earnings plummeted 4920.8% in 2023, then skyrocketed 47017.43% in 2025.
  • Over 4 years, Retained Earnings stood at $9570.0 in 2022, then tumbled by 4920.8% to -$461351.0 in 2023, then surged by 104.09% to $18875.0 in 2024, then surged by 47017.43% to $8.9 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $8.9 million, $18875.0, and -$461351.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.